Literature DB >> 8323820

[Cerebral hemorrhage in a case of antiphospholipid antibody syndrome].

I Muraoka1, N Adachi, M Ogashiwa, H Segawa.   

Abstract

We describe a 36-year-old man with antiphospholipid antibody syndrome complicated by cerebral hemorrhage. In December 1991 he was brought to another hospital with sudden onset of left hemiparesis and status epilepticus. He had been well previously. A CT scan and MRI showed a cerebral hematoma located in the right frontoparietal region. Twelve days later he was transferred to our hospital. Although a CT scan, MRI, and cerebral angiography were repeated, they did not reveal any abnormality regarding an etiology. Only persistently abnormal finding in laboratory studies was positive for lupus anticoagulant and anticardiolipin antibody, i.e. antiphospholipid antibodies. There was no serological evidence of SLE or other autoimmune diseases. Stereotactic biopsy of the hematoma wall and scalp artery showed no abnormality. Based on above findings we conclude that antiphospholipid antibodies have played an important role for the hemorrhage. Antiphospholipid antibody syndrome should be considered in a case of an unexplained cerebral hemorrhage especially in a young and normotensive patient.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323820

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  3 in total

Review 1.  [The catastrophic antiphospholipid antibody syndrome: case report and review of the literature].

Authors:  J Hüwel; C Zühlke; P Kostopoulos; C Mann; G F Hamann
Journal:  Nervenarzt       Date:  2015-02       Impact factor: 1.214

Review 2.  A maternal death due to the intracerebral hemorrhage caused by antiphospholipid syndrome: a case report.

Authors:  Bijan Keikhaei; Najmieh Saadati; Mohammad-Reza Mahmoudian-Sani; Mehran Varnaseri
Journal:  Clin Rheumatol       Date:  2021-01-03       Impact factor: 2.980

3.  Intracerebral hemorrhage in a patient with SLE and catastrophic antiphospholipid syndrome (CAPS): report of a case.

Authors:  Panagiota Boura; Savas Papadopoulos; Konstantinos Tselios; Panagiotis Skendros; Olga Dioritou; Georgios Malamis; Pantelis Makris; Nikolaos Lefkos
Journal:  Clin Rheumatol       Date:  2005-05-24       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.